Scientific letter
Can we decrease the risk of complex liver surgery with the new GLP1 and GIP analogues?
¿Podemos disminuir el riesgo de las cirugías hepáticas complejas con los nuevos análogos de GLP 1 y GIP?
Iago Justoa,b,
, María Calatayudc, Javier Salamancad, María Camarad, Alvaro García-Sesmaa,b, Carmelo Loinaza,b
Corresponding author
ijusto@ucm.es
Corresponding author at: Unit of Hepato-Pancreato-Biliary Surgery and Abdominal Organ Transplantation, “Doce de Octubre” University Hospital, 6th floor, Outpatient Clinic, Ctra Andalucía km 5,4, 28041 Madrid, Spain.
Corresponding author at: Unit of Hepato-Pancreato-Biliary Surgery and Abdominal Organ Transplantation, “Doce de Octubre” University Hospital, 6th floor, Outpatient Clinic, Ctra Andalucía km 5,4, 28041 Madrid, Spain.
a Unit of Hepato-Pancreato-Biliary Surgery and Abdominal Organ Transplantation, Doce de Octubre University Hospital, Instituto de Investigación (imas12), Spain
b Department of Surgery, Faculty of Medicine, Complutense University, Madrid, Spain
c Endocrinology and Nutrition Department Doce de Octubre University Hospital, Instituto de Investigación (imas12), Spain
d Pathology Department Doce de Octubre University Hospital, Instituto de Investigación (imas12), Spain
